Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1954;10:331-337

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by TAYLOR, A.
Right arrow Articles by WRIGHT, I. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by TAYLOR, A.
Right arrow Articles by WRIGHT, I. S.

(Circulation. 1954;10:331.)
© 1954 American Heart Association, Inc.


Intravenous Trypsin

ALEXANDER TAYLOR M.B., CH.B. (EDIN.)1 IRVING S. WRIGHT M.D.1

1 From the Department of Medicine of the Cornell University Medical College and the New York Hospital, New York, N. Y.

Studies were carried out regarding the effect of intravenous trypsin on rabbits. These included investigations into the toxicity and the tendency for the production of intravascular coagulation. The effect on artificial preformed thrombi was also observed. It was found that in the doses used, the intravenous administration of trypsin was not efficacious in the treatment of intravascular thrombosis. These studies failed to provide evidence to justify its use as a therapeutic agent in man.